CRP and rheumatoid arthritis: Participants in the control group tended to have slightly higher RA disease activity measures (except for CRP levels) and receive more conventional synthetic DMARDs (csDMARDS), steroids, and NSAIDs, but similar proportion of biologic DMARDs (bDMARDs) than those in the intervention group.